Oklahoma reaches $250 million opioid settlement with drug distributors

Oklahoma reaches $250 million opioid settlement with drug distributors

Stock Markets 3 minutes ago (Jun 27, 2022 05:20PM ET)

(C) Reuters.

(Reuters) – Oklahoma Attorney General John O’Connor said on Monday his state reached a $250 million settlement with Amerisource Bergen Corp, Cardinal Health Inc (NYSE:CAH) and McKesson Corp (NYSE:MCK) to resolve allegations the drug distributors contributed to the opioid epidemic in the state.

Oklahoma reaches $250 million opioid settlement with drug distributors

Reuters, Dow Jones move to unseal ZTE case recordsBy Reuters – Jun 27, 2022

By Karen Freifeld (Reuters) – Reuters and Dow Jones on Monday brought a motion to unseal records in the U.S. case against China’s ZTE Corp (HK:0763), arguing there is a right to…

Nike revenue beats as Europe demand overshadows China sales slumpBy Reuters – Jun 27, 2022

(Reuters) -Nike Inc beat estimates for quarterly revenue on Monday, as strong demand for its athletic apparel and sneakers in Europe helped the company counter lower sales in…

Morgan Stanley Announces 11% Dividend Hike and $20B Buyback Following Stress TestBy Investing.com – Jun 27, 2022

By Davit Kirakosyan
Following the results of the 2022 stress test, Morgan Stanley (NYSE:MS) announced it will increase the quarterly dividend on its common stock 11% to $0.775…

Our Apps

Terms And Conditions
Privacy Policy
Risk Warning

(C) 2007-2022 Fusion Media Limited. All Rights Reserved.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.